Ultragenyx Pharmaceutical RARE Treasury Stock, Value
Treasury Stock, Value at other companies
Other financials
Where this comes from
Reported directly by Ultragenyx Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockValue.
The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ultragenyx Pharmaceutical's treasury stock, value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ultragenyx Pharmaceutical's treasury stock, value?
- Ultragenyx Pharmaceutical (RARE) reported treasury stock, value of $10M in Q1 2026.
- How has Ultragenyx Pharmaceutical's treasury stock, value changed year-over-year?
- Ultragenyx Pharmaceutical's treasury stock, value increased by 32.2% year-over-year, from $7.57M to $10M.
- What does treasury stock, value mean?
- This represents the cost of common shares that the company has repurchased from the open market and holds in its treasury. Treasury stock reduces total shareholders' equity and is often used for employee stock compensation plans or to return capital to shareholders. It is recorded as a contra-equity account.